

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.95243075 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 5.22821134 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.22821134 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 5.10428854 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.78409536 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.71978611 |
| 7 | respiratory electron transport chain (GO:0022904) | 4.48201586 |
| 8 | electron transport chain (GO:0022900) | 4.37010589 |
| 9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.27515331 |
| 10 | respiratory burst (GO:0045730) | 4.20038209 |
| 11 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.19269472 |
| 12 | protein complex biogenesis (GO:0070271) | 3.87993569 |
| 13 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.87899500 |
| 14 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.84973266 |
| 15 | NADH dehydrogenase complex assembly (GO:0010257) | 3.84973266 |
| 16 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.84973266 |
| 17 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.83041547 |
| 18 | negative regulation of ligase activity (GO:0051352) | 3.81503378 |
| 19 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.81503378 |
| 20 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.75848797 |
| 21 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.73547291 |
| 22 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.71765626 |
| 23 | oxidative phosphorylation (GO:0006119) | 3.65673382 |
| 24 | mast cell activation (GO:0045576) | 3.62398372 |
| 25 | protein targeting to mitochondrion (GO:0006626) | 3.62103002 |
| 26 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.61624020 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 3.61037996 |
| 28 | respiratory chain complex IV assembly (GO:0008535) | 3.60762246 |
| 29 | DNA deamination (GO:0045006) | 3.60253066 |
| 30 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.59481282 |
| 31 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.58227952 |
| 32 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.54962668 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.54138434 |
| 34 | pseudouridine synthesis (GO:0001522) | 3.53080593 |
| 35 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.51469979 |
| 36 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.51469979 |
| 37 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.51103923 |
| 38 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.51103923 |
| 39 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.51103923 |
| 40 | rRNA modification (GO:0000154) | 3.46115987 |
| 41 | cytochrome complex assembly (GO:0017004) | 3.43751201 |
| 42 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.36570789 |
| 43 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.36570789 |
| 44 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.36324005 |
| 45 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.36064624 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.35391592 |
| 47 | regulation of mitochondrial translation (GO:0070129) | 3.34842263 |
| 48 | cellular response to interferon-beta (GO:0035458) | 3.34143094 |
| 49 | modulation by symbiont of host immune response (GO:0052553) | 3.33852110 |
| 50 | positive regulation by symbiont of host defense response (GO:0052509) | 3.33852110 |
| 51 | modulation by symbiont of host defense response (GO:0052031) | 3.33852110 |
| 52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.33852110 |
| 53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.33852110 |
| 54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.33852110 |
| 55 | defense response to protozoan (GO:0042832) | 3.33817169 |
| 56 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.30095319 |
| 57 | neutrophil activation (GO:0042119) | 3.28580710 |
| 58 | establishment of protein localization to mitochondrion (GO:0072655) | 3.28479969 |
| 59 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.28160187 |
| 60 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.28160187 |
| 61 | CENP-A containing nucleosome assembly (GO:0034080) | 3.27963148 |
| 62 | protein localization to mitochondrion (GO:0070585) | 3.26786027 |
| 63 | positive regulation of ligase activity (GO:0051351) | 3.24701675 |
| 64 | ribosomal large subunit biogenesis (GO:0042273) | 3.24670840 |
| 65 | granulocyte activation (GO:0036230) | 3.16609962 |
| 66 | purine nucleobase biosynthetic process (GO:0009113) | 3.15668475 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 3.14104786 |
| 68 | microglial cell activation (GO:0001774) | 3.13977087 |
| 69 | chromatin remodeling at centromere (GO:0031055) | 3.13041630 |
| 70 | positive regulation of chemokine secretion (GO:0090197) | 3.11721454 |
| 71 | response to interferon-beta (GO:0035456) | 3.08279721 |
| 72 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.05721684 |
| 73 | ATP biosynthetic process (GO:0006754) | 3.05270155 |
| 74 | response to protozoan (GO:0001562) | 3.04580293 |
| 75 | termination of RNA polymerase III transcription (GO:0006386) | 3.03915267 |
| 76 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.03915267 |
| 77 | leukocyte aggregation (GO:0070486) | 3.02799306 |
| 78 | response to peptidoglycan (GO:0032494) | 3.02248186 |
| 79 | purine nucleotide salvage (GO:0032261) | 3.02185665 |
| 80 | establishment of integrated proviral latency (GO:0075713) | 2.98012363 |
| 81 | regulation of B cell differentiation (GO:0045577) | 2.97916982 |
| 82 | protein maturation by protein folding (GO:0022417) | 2.97177156 |
| 83 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.96591201 |
| 84 | ribosomal small subunit assembly (GO:0000028) | 2.96384631 |
| 85 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.94020932 |
| 86 | deoxyribose phosphate catabolic process (GO:0046386) | 2.92197455 |
| 87 | aerobic respiration (GO:0009060) | 2.92139726 |
| 88 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.90704600 |
| 89 | B cell receptor signaling pathway (GO:0050853) | 2.90169831 |
| 90 | ribosome assembly (GO:0042255) | 2.89718885 |
| 91 | cullin deneddylation (GO:0010388) | 2.89646609 |
| 92 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.89335258 |
| 93 | cellular response to exogenous dsRNA (GO:0071360) | 2.89049373 |
| 94 | leukocyte degranulation (GO:0043299) | 2.88736369 |
| 95 | axon ensheathment in central nervous system (GO:0032291) | 2.88254210 |
| 96 | central nervous system myelination (GO:0022010) | 2.88254210 |
| 97 | hydrogen ion transmembrane transport (GO:1902600) | 2.87214663 |
| 98 | protein deneddylation (GO:0000338) | 2.86897614 |
| 99 | translation (GO:0006412) | 2.86851978 |
| 100 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.86533134 |
| 101 | regulation of ligase activity (GO:0051340) | 2.86113299 |
| 102 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.85578447 |
| 103 | positive regulation of antigen processing and presentation (GO:0002579) | 2.83225688 |
| 104 | establishment of viral latency (GO:0019043) | 2.82634292 |
| 105 | amyloid precursor protein catabolic process (GO:0042987) | 2.82597819 |
| 106 | positive regulation of interferon-alpha production (GO:0032727) | 2.82426167 |
| 107 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.80774761 |
| 108 | regulation of cellular amine metabolic process (GO:0033238) | 2.80440085 |
| 109 | phagocytosis, engulfment (GO:0006911) | 2.80259223 |
| 110 | macrophage activation involved in immune response (GO:0002281) | 2.80134062 |
| 111 | mitochondrial transport (GO:0006839) | 2.79371777 |
| 112 | response to muramyl dipeptide (GO:0032495) | 2.79058673 |
| 113 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.75065806 |
| 114 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.74648031 |
| 115 | deoxyribonucleotide catabolic process (GO:0009264) | 2.74482589 |
| 116 | spliceosomal snRNP assembly (GO:0000387) | 2.74314685 |
| 117 | purine-containing compound salvage (GO:0043101) | 2.73793767 |
| 118 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.73704849 |
| 119 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73664674 |
| 120 | maturation of SSU-rRNA (GO:0030490) | 2.72833165 |
| 121 | negative regulation of protein ubiquitination (GO:0031397) | 2.72620948 |
| 122 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.72440693 |
| 123 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.72440693 |
| 124 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.72336809 |
| 125 | DNA replication checkpoint (GO:0000076) | 2.71474927 |
| 126 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.71365866 |
| 127 | T cell migration (GO:0072678) | 2.69937808 |
| 128 | regulation of interferon-alpha production (GO:0032647) | 2.69081287 |
| 129 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.68472875 |
| 130 | histone mRNA metabolic process (GO:0008334) | 2.67980177 |
| 131 | proteasome assembly (GO:0043248) | 2.66792885 |
| 132 | rRNA processing (GO:0006364) | 2.65484702 |
| 133 | positive regulation of cell cycle arrest (GO:0071158) | 2.65293884 |
| 134 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.65163332 |
| 135 | protein-cofactor linkage (GO:0018065) | 2.64566098 |
| 136 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.64565907 |
| 137 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.64565907 |
| 138 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.64339203 |
| 139 | B cell mediated immunity (GO:0019724) | 2.63432691 |
| 140 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.62833451 |
| 141 | cellular component biogenesis (GO:0044085) | 2.62694993 |
| 142 | signal peptide processing (GO:0006465) | 2.62337599 |
| 143 | nucleobase biosynthetic process (GO:0046112) | 2.61140335 |
| 144 | amyloid precursor protein metabolic process (GO:0042982) | 2.59060514 |
| 145 | IMP biosynthetic process (GO:0006188) | 2.58684176 |
| 146 | myeloid leukocyte activation (GO:0002274) | 2.57825112 |
| 147 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.55290363 |
| 148 | fatty acid elongation (GO:0030497) | 2.53897161 |
| 149 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.52290058 |
| 150 | myeloid dendritic cell activation (GO:0001773) | 2.50944265 |
| 151 | platelet dense granule organization (GO:0060155) | 2.50750819 |
| 152 | positive regulation of interleukin-17 production (GO:0032740) | 2.50671098 |
| 153 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.46891232 |
| 154 | regulation of antigen processing and presentation (GO:0002577) | 2.46446837 |
| 155 | regulation of interleukin-17 production (GO:0032660) | 2.46286490 |
| 156 | regulation of lymphocyte migration (GO:2000401) | 2.44237038 |
| 157 | GPI anchor biosynthetic process (GO:0006506) | 2.42483965 |
| 158 | regulation of T cell migration (GO:2000404) | 2.41950588 |
| 159 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.39802814 |
| 160 | T-helper 1 type immune response (GO:0042088) | 2.38139063 |
| 161 | protein neddylation (GO:0045116) | 2.38038397 |
| 162 | negative regulation of interleukin-17 production (GO:0032700) | 2.37303707 |
| 163 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.36490772 |
| 164 | positive regulation of mast cell activation (GO:0033005) | 2.34823662 |
| 165 | sequestering of actin monomers (GO:0042989) | 2.34707471 |
| 166 | macrophage activation (GO:0042116) | 2.34332162 |
| 167 | NIK/NF-kappaB signaling (GO:0038061) | 2.34246208 |
| 168 | ribosomal small subunit biogenesis (GO:0042274) | 2.33519437 |
| 169 | aldehyde catabolic process (GO:0046185) | 2.32788657 |
| 170 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.31631518 |
| 171 | chaperone-mediated protein transport (GO:0072321) | 2.31073665 |
| 172 | regulation of mast cell activation (GO:0033003) | 2.29157013 |
| 173 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.28863160 |
| 174 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.28616619 |
| 175 | superoxide anion generation (GO:0042554) | 2.27391933 |
| 176 | mast cell degranulation (GO:0043303) | 2.26359145 |
| 177 | mast cell activation involved in immune response (GO:0002279) | 2.26359145 |
| 178 | positive regulation of lymphocyte migration (GO:2000403) | 2.25047479 |
| 179 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.24476196 |
| 180 | myeloid dendritic cell differentiation (GO:0043011) | 2.23974162 |
| 181 | cellular response to type I interferon (GO:0071357) | 2.23192920 |
| 182 | type I interferon signaling pathway (GO:0060337) | 2.23192920 |
| 183 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.22142665 |
| 184 | cellular extravasation (GO:0045123) | 2.21176778 |
| 185 | membrane invagination (GO:0010324) | 2.21146600 |
| 186 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.20167499 |
| 187 | positive regulation of mast cell degranulation (GO:0043306) | 2.20167499 |
| 188 | glycosphingolipid catabolic process (GO:0046479) | 2.19680363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.79249519 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.27234511 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.26834111 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.94873089 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.65748253 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19452501 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.08955987 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.05978753 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.02829341 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.95242796 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83982240 |
| 12 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.70679509 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.70431965 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.59945188 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.57569845 |
| 16 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49864785 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.47047648 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44901038 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43428769 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.42012029 |
| 21 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.38256636 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.35631733 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.31269229 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.28226051 |
| 25 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.14594507 |
| 26 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.13926836 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11339091 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.06451302 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06228800 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94590240 |
| 31 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92284073 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.90867578 |
| 33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.89367646 |
| 34 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.86401509 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.85268185 |
| 36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.83385744 |
| 37 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.81759743 |
| 38 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.81348532 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.78725693 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.77976966 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77520384 |
| 42 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74926719 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72105632 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.71775244 |
| 45 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.70497811 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67840255 |
| 47 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.67772724 |
| 48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66685254 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.64604227 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.63565128 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.61410023 |
| 52 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61192815 |
| 53 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.58033483 |
| 54 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.57262706 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56756326 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56156822 |
| 57 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.54536192 |
| 58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.52468198 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.51246579 |
| 60 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50854755 |
| 61 | * MYB_26560356_Chip-Seq_TH2_Human | 1.49751723 |
| 62 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.48635885 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48374346 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45937749 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43706806 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43619038 |
| 67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42902168 |
| 68 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41386990 |
| 69 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.40321803 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38711661 |
| 71 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.35794383 |
| 72 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.35506799 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34837590 |
| 74 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.33194468 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32552822 |
| 76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.32121371 |
| 77 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.32018806 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31589451 |
| 79 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31564252 |
| 80 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.31418372 |
| 81 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.31353653 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30370646 |
| 83 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.29893460 |
| 84 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.27952386 |
| 85 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27603098 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26661779 |
| 87 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26336783 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25562134 |
| 89 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.22999314 |
| 90 | MYB_26560356_Chip-Seq_TH1_Human | 1.22663899 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21732454 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21646395 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21605563 |
| 94 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.21421834 |
| 95 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.20859359 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 1.20152994 |
| 97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.19405498 |
| 98 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19094060 |
| 99 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18631284 |
| 100 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.18370535 |
| 101 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17863367 |
| 102 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16302589 |
| 103 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.13451442 |
| 104 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.13267151 |
| 105 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.10759977 |
| 106 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.09220503 |
| 107 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.09069431 |
| 108 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09015574 |
| 109 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08994790 |
| 110 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08110658 |
| 111 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.07836718 |
| 112 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.06192947 |
| 113 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.04234989 |
| 114 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02469368 |
| 115 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00238767 |
| 116 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99676440 |
| 117 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98192169 |
| 118 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96673379 |
| 119 | MAF_26560356_Chip-Seq_TH2_Human | 0.96499620 |
| 120 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.95937791 |
| 121 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.93902470 |
| 122 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.93740550 |
| 123 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.93140025 |
| 124 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.92605903 |
| 125 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92229465 |
| 126 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92054814 |
| 127 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91293615 |
| 128 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.91273308 |
| 129 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90992613 |
| 130 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88423696 |
| 131 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.80329309 |
| 132 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.80182776 |
| 133 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.78431767 |
| 134 | EWS_26573619_Chip-Seq_HEK293_Human | 0.76462769 |
| 135 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.73076442 |
| 136 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.72989823 |
| 137 | AR_20517297_ChIP-Seq_VCAP_Human | 0.72985401 |
| 138 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.72935196 |
| 139 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.70034642 |
| 140 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.69397002 |
| 141 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.69098770 |
| 142 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.67355780 |
| 143 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.67355780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.00013951 |
| 2 | MP0006082_CNS_inflammation | 3.49390790 |
| 3 | MP0005671_abnormal_response_to | 3.19691760 |
| 4 | MP0009785_altered_susceptibility_to | 3.19594918 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.00565671 |
| 6 | MP0003436_decreased_susceptibility_to | 2.99818196 |
| 7 | MP0002419_abnormal_innate_immunity | 2.93076193 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.84662172 |
| 9 | MP0006036_abnormal_mitochondrial_physio | 2.83339686 |
| 10 | MP0003724_increased_susceptibility_to | 2.81585084 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.77923571 |
| 12 | MP0005025_abnormal_response_to | 2.70331501 |
| 13 | MP0008058_abnormal_DNA_repair | 2.62455020 |
| 14 | MP0001800_abnormal_humoral_immune | 2.55403238 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.52708087 |
| 16 | MP0002723_abnormal_immune_serum | 2.48729630 |
| 17 | MP0010094_abnormal_chromosome_stability | 2.48181933 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.44903382 |
| 19 | MP0000685_abnormal_immune_system | 2.42343548 |
| 20 | MP0001790_abnormal_immune_system | 2.37894996 |
| 21 | MP0005387_immune_system_phenotype | 2.37894996 |
| 22 | MP0009840_abnormal_foam_cell | 2.37051547 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.36317351 |
| 24 | MP0004957_abnormal_blastocyst_morpholog | 2.35755126 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.34194415 |
| 26 | MP0001819_abnormal_immune_cell | 2.32712609 |
| 27 | MP0000920_abnormal_myelination | 2.12026257 |
| 28 | MP0006035_abnormal_mitochondrial_morpho | 2.11892832 |
| 29 | MP0003786_premature_aging | 2.09909584 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 2.04166426 |
| 31 | MP0003111_abnormal_nucleus_morphology | 1.95800145 |
| 32 | MP0001853_heart_inflammation | 1.86292742 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.85459103 |
| 34 | MP0000716_abnormal_immune_system | 1.81635269 |
| 35 | MP0002398_abnormal_bone_marrow | 1.79011418 |
| 36 | MP0008007_abnormal_cellular_replicative | 1.77477247 |
| 37 | MP0002405_respiratory_system_inflammati | 1.77212614 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.77124135 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.75322614 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.72972568 |
| 41 | MP0009697_abnormal_copulation | 1.72574127 |
| 42 | MP0006054_spinal_hemorrhage | 1.69448449 |
| 43 | MP0001986_abnormal_taste_sensitivity | 1.68530479 |
| 44 | MP0003077_abnormal_cell_cycle | 1.67261251 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.66999913 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.65919002 |
| 47 | MP0008469_abnormal_protein_level | 1.64324564 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.63371386 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.62272411 |
| 50 | MP0003186_abnormal_redox_activity | 1.62112504 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.61015829 |
| 52 | MP0003690_abnormal_glial_cell | 1.58346808 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.57553210 |
| 54 | MP0002429_abnormal_blood_cell | 1.53194980 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.51730574 |
| 56 | MP0001873_stomach_inflammation | 1.49362326 |
| 57 | MP0005451_abnormal_body_composition | 1.48994339 |
| 58 | MP0002722_abnormal_immune_system | 1.48221254 |
| 59 | MP0003303_peritoneal_inflammation | 1.45294373 |
| 60 | MP0009764_decreased_sensitivity_to | 1.43050319 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.41548558 |
| 62 | MP0008260_abnormal_autophagy | 1.40227506 |
| 63 | MP0002933_joint_inflammation | 1.37717132 |
| 64 | MP0000343_altered_response_to | 1.35529684 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.33474177 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.32166484 |
| 67 | MP0008932_abnormal_embryonic_tissue | 1.30431142 |
| 68 | MP0002006_tumorigenesis | 1.30099627 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.29995091 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.29995091 |
| 71 | MP0003075_altered_response_to | 1.27034065 |
| 72 | MP0000358_abnormal_cell_content/ | 1.26051537 |
| 73 | MP0004147_increased_porphyrin_level | 1.24592703 |
| 74 | MP0003195_calcinosis | 1.22450402 |
| 75 | MP0002102_abnormal_ear_morphology | 1.19429156 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 1.18617743 |
| 77 | MP0005310_abnormal_salivary_gland | 1.17337605 |
| 78 | MP0003866_abnormal_defecation | 1.08545690 |
| 79 | MP0003183_abnormal_peptide_metabolism | 1.08468272 |
| 80 | MP0008872_abnormal_physiological_respon | 1.07283784 |
| 81 | MP0004947_skin_inflammation | 1.07279225 |
| 82 | MP0000858_altered_metastatic_potential | 1.06802605 |
| 83 | MP0002132_abnormal_respiratory_system | 1.05213505 |
| 84 | MP0001764_abnormal_homeostasis | 1.04949298 |
| 85 | MP0000490_abnormal_crypts_of | 1.03667498 |
| 86 | MP0000015_abnormal_ear_pigmentation | 1.03354989 |
| 87 | MP0002163_abnormal_gland_morphology | 1.03055711 |
| 88 | MP0004510_myositis | 1.01701605 |
| 89 | MP0000604_amyloidosis | 1.01463450 |
| 90 | MP0000313_abnormal_cell_death | 0.99913209 |
| 91 | MP0005166_decreased_susceptibility_to | 0.98342952 |
| 92 | MP0001851_eye_inflammation | 0.96290423 |
| 93 | MP0009763_increased_sensitivity_to | 0.95999710 |
| 94 | MP0000372_irregular_coat_pigmentation | 0.95399024 |
| 95 | MP0009278_abnormal_bone_marrow | 0.92416972 |
| 96 | MP0008057_abnormal_DNA_replication | 0.92117599 |
| 97 | MP0005636_abnormal_mineral_homeostasis | 0.90512917 |
| 98 | MP0004381_abnormal_hair_follicle | 0.90355177 |
| 99 | MP0003011_delayed_dark_adaptation | 0.89469314 |
| 100 | MP0005408_hypopigmentation | 0.88703294 |
| 101 | MP0004782_abnormal_surfactant_physiolog | 0.88634410 |
| 102 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88514613 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.88209570 |
| 104 | MP0003693_abnormal_embryo_hatching | 0.87746797 |
| 105 | MP0005165_increased_susceptibility_to | 0.85054118 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.84834857 |
| 107 | MP0001905_abnormal_dopamine_level | 0.83971437 |
| 108 | MP0008873_increased_physiological_sensi | 0.83303660 |
| 109 | MP0000703_abnormal_thymus_morphology | 0.82673452 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82620620 |
| 111 | MP0005332_abnormal_amino_acid | 0.81757620 |
| 112 | MP0002998_abnormal_bone_remodeling | 0.81693340 |
| 113 | MP0002138_abnormal_hepatobiliary_system | 0.81065923 |
| 114 | MP0005164_abnormal_response_to | 0.79890316 |
| 115 | MP0003448_altered_tumor_morphology | 0.79552712 |
| 116 | MP0005409_darkened_coat_color | 0.78900007 |
| 117 | MP0006292_abnormal_olfactory_placode | 0.76291799 |
| 118 | MP0005171_absent_coat_pigmentation | 0.75553986 |
| 119 | MP0001542_abnormal_bone_strength | 0.75317851 |
| 120 | MP0001529_abnormal_vocalization | 0.75051682 |
| 121 | MP0004883_abnormal_blood_vessel | 0.73922187 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.73710348 |
| 123 | MP0002736_abnormal_nociception_after | 0.73392693 |
| 124 | MP0009379_abnormal_foot_pigmentation | 0.73227945 |
| 125 | MP0008877_abnormal_DNA_methylation | 0.70019909 |
| 126 | MP0003136_yellow_coat_color | 0.69287548 |
| 127 | MP0004142_abnormal_muscle_tone | 0.69263445 |
| 128 | MP0000249_abnormal_blood_vessel | 0.68329127 |
| 129 | MP0001663_abnormal_digestive_system | 0.66876370 |
| 130 | MP0005390_skeleton_phenotype | 0.65496735 |
| 131 | MP0002019_abnormal_tumor_incidence | 0.61536200 |
| 132 | MP0003718_maternal_effect | 0.59617914 |
| 133 | MP0002095_abnormal_skin_pigmentation | 0.58699561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.52101604 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.32207185 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.98172224 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.93837948 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.83311273 |
| 6 | Acute encephalopathy (HP:0006846) | 4.71144862 |
| 7 | Increased CSF lactate (HP:0002490) | 4.54048876 |
| 8 | Progressive macrocephaly (HP:0004481) | 4.47106160 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.21635104 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.16559696 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 4.14366387 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 3.95838210 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.77264190 |
| 14 | Increased hepatocellular lipid droplets (HP:0006565) | 3.60666174 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.59892292 |
| 16 | Cerebral edema (HP:0002181) | 3.55934075 |
| 17 | Recurrent skin infections (HP:0001581) | 3.54983838 |
| 18 | Lipid accumulation in hepatocytes (HP:0006561) | 3.49403839 |
| 19 | Hepatosplenomegaly (HP:0001433) | 3.38942787 |
| 20 | Myositis (HP:0100614) | 3.33990430 |
| 21 | Chronic otitis media (HP:0000389) | 3.20917012 |
| 22 | Glomerulonephritis (HP:0000099) | 3.19492276 |
| 23 | IgM deficiency (HP:0002850) | 3.19215835 |
| 24 | Abnormality of glycolipid metabolism (HP:0010969) | 3.14893798 |
| 25 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.14893798 |
| 26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.14893798 |
| 27 | Increased serum lactate (HP:0002151) | 3.14016151 |
| 28 | Stomatitis (HP:0010280) | 3.09589251 |
| 29 | Petechiae (HP:0000967) | 3.07926958 |
| 30 | Respiratory failure (HP:0002878) | 3.07667783 |
| 31 | Lactic acidosis (HP:0003128) | 3.06925849 |
| 32 | Increased intramyocellular lipid droplets (HP:0012240) | 3.02764483 |
| 33 | Axonal loss (HP:0003447) | 3.01371127 |
| 34 | Obstructive lung disease (HP:0006536) | 2.99522298 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99522298 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.93116514 |
| 37 | Increased serum pyruvate (HP:0003542) | 2.86267259 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.84603888 |
| 39 | Purpura (HP:0000979) | 2.78965521 |
| 40 | Recurrent fungal infections (HP:0002841) | 2.76491547 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 2.73275918 |
| 42 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.69988734 |
| 43 | Congenital, generalized hypertrichosis (HP:0004540) | 2.69627598 |
| 44 | Increased muscle lipid content (HP:0009058) | 2.67416560 |
| 45 | Increased cerebral lipofuscin (HP:0011813) | 2.64137838 |
| 46 | Recurrent viral infections (HP:0004429) | 2.59602013 |
| 47 | Vasculitis (HP:0002633) | 2.58865245 |
| 48 | Dysostosis multiplex (HP:0000943) | 2.58737916 |
| 49 | Meningitis (HP:0001287) | 2.56107732 |
| 50 | Abnormality of glycolysis (HP:0004366) | 2.52799414 |
| 51 | Exercise intolerance (HP:0003546) | 2.52466958 |
| 52 | Cerebral hypomyelination (HP:0006808) | 2.48768535 |
| 53 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48401581 |
| 54 | CNS demyelination (HP:0007305) | 2.43212683 |
| 55 | Lethargy (HP:0001254) | 2.42567007 |
| 56 | Gastrointestinal stroma tumor (HP:0100723) | 2.42513913 |
| 57 | Leukodystrophy (HP:0002415) | 2.42170486 |
| 58 | Macrocytic anemia (HP:0001972) | 2.39234844 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.38374900 |
| 60 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.36854106 |
| 61 | Pustule (HP:0200039) | 2.36102451 |
| 62 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.32908281 |
| 63 | Abnormality of alanine metabolism (HP:0010916) | 2.32908281 |
| 64 | Hyperalaninemia (HP:0003348) | 2.32908281 |
| 65 | Abnormal protein glycosylation (HP:0012346) | 2.32868066 |
| 66 | Abnormal glycosylation (HP:0012345) | 2.32868066 |
| 67 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.32868066 |
| 68 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.32868066 |
| 69 | Abnormality of methionine metabolism (HP:0010901) | 2.32783013 |
| 70 | Microvesicular hepatic steatosis (HP:0001414) | 2.32104960 |
| 71 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.30361344 |
| 72 | Abnormality of B cell number (HP:0010975) | 2.30356245 |
| 73 | Respiratory difficulties (HP:0002880) | 2.30256222 |
| 74 | Optic neuritis (HP:0100653) | 2.30163110 |
| 75 | Retrobulbar optic neuritis (HP:0100654) | 2.30163110 |
| 76 | Recurrent pneumonia (HP:0006532) | 2.29843436 |
| 77 | Abnormal number of erythroid precursors (HP:0012131) | 2.29722328 |
| 78 | Optic disc pallor (HP:0000543) | 2.28861481 |
| 79 | Panhypogammaglobulinemia (HP:0003139) | 2.28630526 |
| 80 | Orchitis (HP:0100796) | 2.27488538 |
| 81 | Thrombocytosis (HP:0001894) | 2.27333861 |
| 82 | Cellulitis (HP:0100658) | 2.27152486 |
| 83 | Degeneration of anterior horn cells (HP:0002398) | 2.26888849 |
| 84 | Abnormality of the anterior horn cell (HP:0006802) | 2.26888849 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26154576 |
| 86 | B lymphocytopenia (HP:0010976) | 2.24183072 |
| 87 | Progressive neurologic deterioration (HP:0002344) | 2.21185031 |
| 88 | Prolonged neonatal jaundice (HP:0006579) | 2.20858559 |
| 89 | Recurrent cutaneous fungal infections (HP:0011370) | 2.20727120 |
| 90 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.20727120 |
| 91 | Parakeratosis (HP:0001036) | 2.20310432 |
| 92 | Poor head control (HP:0002421) | 2.20205549 |
| 93 | Agnosia (HP:0010524) | 2.20021976 |
| 94 | Exertional dyspnea (HP:0002875) | 2.19229740 |
| 95 | Basal ganglia calcification (HP:0002135) | 2.19016697 |
| 96 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.18534598 |
| 97 | Methylmalonic acidemia (HP:0002912) | 2.17950801 |
| 98 | Methylmalonic aciduria (HP:0012120) | 2.17126546 |
| 99 | Nausea (HP:0002018) | 2.16903808 |
| 100 | Lymphopenia (HP:0001888) | 2.16843440 |
| 101 | Leukocytosis (HP:0001974) | 2.16138327 |
| 102 | Increased IgM level (HP:0003496) | 2.15513784 |
| 103 | Pancytopenia (HP:0001876) | 2.14102755 |
| 104 | Reduced antithrombin III activity (HP:0001976) | 2.13121198 |
| 105 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.12024580 |
| 106 | Eosinophilia (HP:0001880) | 2.11126878 |
| 107 | Abnormality of T cell physiology (HP:0011840) | 2.10993561 |
| 108 | Amyloidosis (HP:0011034) | 2.10517480 |
| 109 | Epistaxis (HP:0000421) | 2.09803575 |
| 110 | Testicular atrophy (HP:0000029) | 2.09416932 |
| 111 | Chronic diarrhea (HP:0002028) | 2.08416566 |
| 112 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.08231080 |
| 113 | Abnormality of T cells (HP:0002843) | 2.07390113 |
| 114 | Neutropenia (HP:0001875) | 2.07327856 |
| 115 | Abnormality of eosinophils (HP:0001879) | 2.06306069 |
| 116 | Urticaria (HP:0001025) | 2.06270027 |
| 117 | Prolonged bleeding time (HP:0003010) | 2.05972448 |
| 118 | IgG deficiency (HP:0004315) | 2.05670579 |
| 119 | Granulocytopenia (HP:0001913) | 2.05202331 |
| 120 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.04025968 |
| 121 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.04025968 |
| 122 | Emotional lability (HP:0000712) | 2.04021003 |
| 123 | Generalized aminoaciduria (HP:0002909) | 2.03891367 |
| 124 | Thoracic kyphosis (HP:0002942) | 2.03673342 |
| 125 | Type I transferrin isoform profile (HP:0003642) | 2.03047940 |
| 126 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02465646 |
| 127 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.01653339 |
| 128 | Oral leukoplakia (HP:0002745) | 2.01127241 |
| 129 | Hypergammaglobulinemia (HP:0010702) | 2.00456143 |
| 130 | Complement deficiency (HP:0004431) | 2.00235631 |
| 131 | Impaired platelet aggregation (HP:0003540) | 1.99439458 |
| 132 | Abnormal platelet function (HP:0011869) | 1.99439458 |
| 133 | Abnormal spermatogenesis (HP:0008669) | 1.98707209 |
| 134 | Hepatocellular necrosis (HP:0001404) | 1.98606528 |
| 135 | Short middle phalanx of the 5th finger (HP:0004220) | 1.97556178 |
| 136 | Abnormality of renal resorption (HP:0011038) | 1.97475942 |
| 137 | Aplastic anemia (HP:0001915) | 1.96784832 |
| 138 | Rough bone trabeculation (HP:0100670) | 1.96433580 |
| 139 | Loss of speech (HP:0002371) | 1.95920812 |
| 140 | Encephalitis (HP:0002383) | 1.95742646 |
| 141 | Gingival bleeding (HP:0000225) | 1.94894802 |
| 142 | Inflammation of the large intestine (HP:0002037) | 1.93699330 |
| 143 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.92926806 |
| 144 | Recurrent lower respiratory tract infections (HP:0002783) | 1.92862769 |
| 145 | Patchy hypopigmentation of hair (HP:0011365) | 1.92396487 |
| 146 | Recurrent bronchitis (HP:0002837) | 1.90965177 |
| 147 | Renal Fanconi syndrome (HP:0001994) | 1.90922086 |
| 148 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.89540223 |
| 149 | Abnormality of serum amino acid levels (HP:0003112) | 1.89284562 |
| 150 | Pallor (HP:0000980) | 1.88926338 |
| 151 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.88388397 |
| 152 | Dicarboxylic aciduria (HP:0003215) | 1.88388397 |
| 153 | Sparse eyelashes (HP:0000653) | 1.87752631 |
| 154 | Gingivitis (HP:0000230) | 1.87248113 |
| 155 | Abnormality of T cell number (HP:0011839) | 1.87152524 |
| 156 | Osteomyelitis (HP:0002754) | 1.85075134 |
| 157 | Agammaglobulinemia (HP:0004432) | 1.84497958 |
| 158 | Lymphoma (HP:0002665) | 1.81119098 |
| 159 | Severe combined immunodeficiency (HP:0004430) | 1.79894696 |
| 160 | Hepatic necrosis (HP:0002605) | 1.79454516 |
| 161 | Autoimmune hemolytic anemia (HP:0001890) | 1.78040121 |
| 162 | X-linked dominant inheritance (HP:0001423) | 1.74513233 |
| 163 | Constricted visual fields (HP:0001133) | 1.71878419 |
| 164 | Abnormality of the prostate (HP:0008775) | 1.70972904 |
| 165 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.70487837 |
| 166 | Spastic paraparesis (HP:0002313) | 1.68433890 |
| 167 | Azoospermia (HP:0000027) | 1.67514944 |
| 168 | Reticulocytopenia (HP:0001896) | 1.66009951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.60038678 |
| 2 | VRK2 | 3.39617361 |
| 3 | BLK | 2.77426122 |
| 4 | NME2 | 2.72355285 |
| 5 | TXK | 2.72123113 |
| 6 | MAP3K14 | 2.56154472 |
| 7 | IRAK4 | 2.47452347 |
| 8 | NEK1 | 2.38604493 |
| 9 | TGFBR2 | 2.38510120 |
| 10 | PBK | 2.35776378 |
| 11 | KIT | 2.32480648 |
| 12 | TBK1 | 2.31426461 |
| 13 | MAP4K2 | 2.26536089 |
| 14 | CSF1R | 2.24605267 |
| 15 | CLK1 | 2.18054257 |
| 16 | STK16 | 2.14630743 |
| 17 | PIM2 | 2.07713211 |
| 18 | TYK2 | 2.02950406 |
| 19 | MST4 | 1.99137078 |
| 20 | SRPK1 | 1.94122886 |
| 21 | TLK1 | 1.93210462 |
| 22 | KDR | 1.91706677 |
| 23 | ZAK | 1.89181160 |
| 24 | IKBKE | 1.87554363 |
| 25 | ZAP70 | 1.83571288 |
| 26 | BUB1 | 1.78503133 |
| 27 | TEC | 1.77369764 |
| 28 | IKBKB | 1.73400047 |
| 29 | PDK2 | 1.72151850 |
| 30 | TESK2 | 1.66899013 |
| 31 | CDC7 | 1.60985385 |
| 32 | RIPK4 | 1.60955805 |
| 33 | NUAK1 | 1.59981351 |
| 34 | BTK | 1.56428582 |
| 35 | EPHB1 | 1.53192377 |
| 36 | IRAK3 | 1.51972120 |
| 37 | GRK7 | 1.46938435 |
| 38 | TNIK | 1.36554918 |
| 39 | SCYL2 | 1.35539064 |
| 40 | ARAF | 1.34952781 |
| 41 | VRK1 | 1.30174382 |
| 42 | LYN | 1.29504706 |
| 43 | SYK | 1.27451172 |
| 44 | TRIM28 | 1.27326157 |
| 45 | STK10 | 1.22792366 |
| 46 | MOS | 1.22723502 |
| 47 | BMPR2 | 1.21260355 |
| 48 | LCK | 1.19836107 |
| 49 | JAK3 | 1.18400596 |
| 50 | CDK19 | 1.18366326 |
| 51 | ITK | 1.17541994 |
| 52 | PLK3 | 1.16330482 |
| 53 | CAMKK2 | 1.15054185 |
| 54 | MAPKAPK5 | 1.12569665 |
| 55 | MAP3K12 | 1.08869856 |
| 56 | ADRBK2 | 1.07500021 |
| 57 | STK39 | 1.03766064 |
| 58 | DAPK1 | 1.00763178 |
| 59 | EIF2AK1 | 0.99972977 |
| 60 | LIMK1 | 0.99214404 |
| 61 | OXSR1 | 0.98293923 |
| 62 | HCK | 0.96703423 |
| 63 | ILK | 0.95219009 |
| 64 | MKNK1 | 0.93568483 |
| 65 | EIF2AK3 | 0.90406786 |
| 66 | CSK | 0.89497538 |
| 67 | FES | 0.88963449 |
| 68 | MAP3K13 | 0.87795435 |
| 69 | MAPK15 | 0.87406125 |
| 70 | NME1 | 0.85631762 |
| 71 | PAK4 | 0.85614988 |
| 72 | WEE1 | 0.83051387 |
| 73 | PIM1 | 0.82554239 |
| 74 | CSNK1G3 | 0.80068889 |
| 75 | BCKDK | 0.79776856 |
| 76 | PLK1 | 0.79598283 |
| 77 | NLK | 0.78581302 |
| 78 | ABL2 | 0.78490436 |
| 79 | BRSK2 | 0.77612787 |
| 80 | TTK | 0.77083450 |
| 81 | GRK1 | 0.75817990 |
| 82 | MUSK | 0.75771607 |
| 83 | DYRK2 | 0.75570747 |
| 84 | BMPR1B | 0.75218334 |
| 85 | PLK2 | 0.71457860 |
| 86 | CDK8 | 0.70249287 |
| 87 | EIF2AK2 | 0.69667616 |
| 88 | MKNK2 | 0.68389845 |
| 89 | AURKB | 0.67870178 |
| 90 | TESK1 | 0.67327290 |
| 91 | TAOK3 | 0.67019002 |
| 92 | MAP3K11 | 0.64364581 |
| 93 | ACVR1B | 0.63875451 |
| 94 | ERBB3 | 0.61588495 |
| 95 | CSNK2A1 | 0.60471257 |
| 96 | ERN1 | 0.58882402 |
| 97 | TRPM7 | 0.57888393 |
| 98 | CSNK1A1L | 0.57479792 |
| 99 | FGR | 0.57404559 |
| 100 | STK4 | 0.56253687 |
| 101 | MAPK4 | 0.54857762 |
| 102 | CSNK2A2 | 0.54019385 |
| 103 | DAPK3 | 0.53811916 |
| 104 | MATK | 0.53598372 |
| 105 | ATR | 0.53268324 |
| 106 | INSRR | 0.53228996 |
| 107 | PRKCQ | 0.51691081 |
| 108 | JAK1 | 0.51662037 |
| 109 | PLK4 | 0.51084095 |
| 110 | CSNK1G1 | 0.51068476 |
| 111 | TNK2 | 0.50859318 |
| 112 | PIK3CG | 0.50259572 |
| 113 | PKN1 | 0.48627660 |
| 114 | MYLK | 0.48344730 |
| 115 | LRRK2 | 0.48036487 |
| 116 | NEK6 | 0.47017331 |
| 117 | PRKCD | 0.45939290 |
| 118 | YES1 | 0.45830040 |
| 119 | RPS6KA5 | 0.45403604 |
| 120 | TIE1 | 0.44067539 |
| 121 | MAP2K3 | 0.43792363 |
| 122 | MAPK12 | 0.43205125 |
| 123 | CHEK2 | 0.42049447 |
| 124 | WNK3 | 0.41986752 |
| 125 | BCR | 0.41356148 |
| 126 | JAK2 | 0.41083489 |
| 127 | MAPKAPK3 | 0.39425990 |
| 128 | CSNK1G2 | 0.38894740 |
| 129 | CCNB1 | 0.38000689 |
| 130 | MAP3K5 | 0.37859505 |
| 131 | PRKG2 | 0.37743641 |
| 132 | ABL1 | 0.37001456 |
| 133 | RPS6KA4 | 0.36934890 |
| 134 | MAP3K8 | 0.35135855 |
| 135 | TSSK6 | 0.35074836 |
| 136 | MARK3 | 0.33952266 |
| 137 | TAOK2 | 0.33510397 |
| 138 | MAPKAPK2 | 0.33161226 |
| 139 | PAK1 | 0.33069987 |
| 140 | ALK | 0.32066829 |
| 141 | GRK6 | 0.32026981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.76902796 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.64600735 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.63337922 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.48989925 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.04475102 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.03687062 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 1.94587470 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 1.92419966 |
| 9 | Protein export_Homo sapiens_hsa03060 | 1.89872847 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.88921813 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.88544090 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 1.86400802 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.80546293 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79282237 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.74064985 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.72595682 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.70989394 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.65166968 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.64725167 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61381419 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.60201575 |
| 22 | DNA replication_Homo sapiens_hsa03030 | 1.59621811 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.58292760 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52211809 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.49059373 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47820133 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.46543246 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.46542135 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45370372 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.43229441 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.40213717 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39422637 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38051757 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37056979 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.36485556 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.36032274 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.33765120 |
| 38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.32493584 |
| 39 | RNA degradation_Homo sapiens_hsa03018 | 1.32354184 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.32010964 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.24560851 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23862909 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22343215 |
| 44 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14785520 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.14238079 |
| 46 | RNA transport_Homo sapiens_hsa03013 | 1.14032630 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 1.13309846 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12891376 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.08926455 |
| 50 | Homologous recombination_Homo sapiens_hsa03440 | 1.08913462 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.08421170 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08073187 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 1.06277796 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05822254 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.01622266 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.00418733 |
| 57 | Parkinsons disease_Homo sapiens_hsa05012 | 0.98979183 |
| 58 | Base excision repair_Homo sapiens_hsa03410 | 0.96967012 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96788258 |
| 60 | Mismatch repair_Homo sapiens_hsa03430 | 0.94721027 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93693040 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.93592921 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92658284 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92136130 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91572141 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91408190 |
| 67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.91248512 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88251870 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86424753 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84766562 |
| 71 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84270452 |
| 72 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83616603 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83216042 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83014888 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.82734296 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82575880 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79703452 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79367202 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79251484 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78055187 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.76465377 |
| 82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76242606 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73495539 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73279609 |
| 85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.72697170 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72677673 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71460531 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.70642558 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70638489 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70375091 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70083360 |
| 92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69485576 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69095705 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.68025644 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66203203 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65196280 |
| 97 | Spliceosome_Homo sapiens_hsa03040 | 0.65146810 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65092326 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63362724 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62807107 |
| 101 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62403314 |
| 102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62223052 |
| 103 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62024677 |
| 104 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.60307422 |
| 105 | Cell cycle_Homo sapiens_hsa04110 | 0.59928180 |
| 106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58972089 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58535844 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58364396 |
| 109 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.57973727 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.57731015 |
| 111 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57600302 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56483523 |
| 113 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55742127 |
| 114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55074683 |
| 115 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.55048780 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55014360 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54861146 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54000114 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50558454 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49341858 |
| 121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47497223 |
| 122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44395839 |
| 123 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41450536 |
| 124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.37266954 |
| 125 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.36248753 |
| 126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31432740 |
| 127 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.30916383 |
| 128 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.27635011 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.24906654 |
| 130 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24052226 |
| 131 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.23724149 |

